Navigation Links
Open access research celebrated
Date:4/14/2009

The winners of BioMed Central's 3rd Annual Research Awards were announced at an awards ceremony at London's Barbican Centre last week. The event was attended by shortlisted authors, eminent researchers from around the world, open access advocates and science journalists.

The Research Awards, now in their third year, recognize excellence in research that has been made universally accessible by open access publication. The Awards celebrate the best medical and biological research published in any of BioMed Central's open access journals in the last year.

The Medicine and Biology Prizes, sponsored by Microsoft Research, were won by the following research articles:

Biology Award Basil Honegger, University of Zrich
Imp-L2, a putative homolog of vertebrate IGF-binding protein 7, counteracts insulin signaling in Drosophila and is essential for starvation resistance
Honegger B, Galic M, Khler K, Wittwer F, Brogiolo W, Hafen E, Stocker H
Journal of Biology 2008, 7:10 (15 April 2008)
http://jbiol.com/content/7/3/10

This research describes the genetic identification of the first functional insulin-like growth factor binding protein ortholog in invertebrates.

Medicine Award Weiqi Yan and Guomin Xiao, Hangzhou Normal University
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial
Xiao G, Wei J, Yan W, Wang W, Lu Z
Critical Care 2008, 12:R61 (30 April 2008)
http://ccforum.com/content/12/2/R61

This study explains how a common component of the contraceptive pill (progesterone) could improve the neurologic outcome for patients with severe head injuries.

This year, three new awards were introduced:

Editor of the Year - Chris Arme, Parasites & Vectors

Case Report of the Year
Derek Rajakumar, University of Saskatchewan
Mycobacterium tuberculosis monoarthritis in a child
Rajakumar D, Rosenberg AM
Pediatric Rheumatology 2008, 6:15 (18 September 2008)
http://www.ped-rheum.com/content/6/1/15

This case demonstrates the unusual ways that tuberculosis can present in our patients and highlights the difficulty in diagnosing non-pulmonary tuberculosis.

Open Access Institute of the Year - University of Nottingham

BioMed Central Publisher Matthew Cockerill said "We are delighted with the diversity and quality of this year's award nominees and would like to congratulate the winners, and those shortlisted, on their exceptional research. We would also like to thank our sponsors, Microsoft Research and Pfizer, whose support made the awards possible."

Guests at the event were treated to a lively routine from Brian Malow, 'the science comedian'. As part of their commitment to open access, Pfizer were proud to be the sponsor the Research Awards Dinner.

Photos and full details of the awards can be found at the BioMed Central Annual Research Awards website (http://www.biomedcentral.com/researchawards/)


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-020-319-222-216
BioMed Central
Source:Eurekalert

Related biology news :

1. Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal
2. Mandate for public access to NIH-funded research poised to become law
3. UK research community gets extended access to ScienceDirect
4. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
5. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
6. SAGE and Hindawi announce landmark open access agreement
7. Top physics laboratories sign up to open access with PhysMath Central
8. Open-access tropical conservation journal launches
9. Excellence in open access research celebrated at BioMed Central awards dinner
10. New chlorine-tolerant, desalination membrane hopes to boost access to clean water
11. Open access to large-scale drug discovery data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... ... Back pain relief technology is now available without a prescription at What ... relief for WAR members. , This spinal restoration platform boasts utilization of technology that ... suffering from chronic back pain. , What A Relief Back Pain Centers ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, ... Drug Administration (FDA) has accepted Mylan,s biologics license application ... through the 351(k) pathway. This product is a proposed ... certain HER2-positive breast cancers. The anticipated FDA goal date ...
(Date:1/11/2017)... , Jan. 11, 2017  GenVec, Inc. ... delivery company, announced today that its chief scientific ... a talk entitled  "AdenoVerse™ platform for translational development ... Biotech Showcase at the upcoming Phacilitate Cell & ... Miami , Florida.  Dr. Brough,s presentation will ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... signed a multi-year license agreement with Poseida Therapeutics Inc, the San Diego based ... genetic data. Poseida Therapeutics selected KBioBox in order to harness KBioBox’s powerful BioEngine ...
Breaking Biology Technology: